Related Experiment Video
Updated: Nov 3, 2025
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.7K
Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction
Guillaume Jean1, Nicolas M Van Mieghem2, Tea Gegenava3
1Institut universitaire de cardiologie et de pneumologie, Université Laval, Québec, Québec, Canada.
Journal of the American College of Cardiology
|June 4, 2021
Summary
Moderate aortic stenosis (AS) significantly increases mortality risk in heart failure with reduced ejection fraction (HFrEF) patients. Aortic valve replacement, particularly transcatheter AVR, improves survival in this population.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Heart Failure Research
Background:
- Moderate aortic stenosis (AS) is linked to poor prognosis in heart failure with reduced left ventricular ejection fraction (HFrEF).
- The independent impact of moderate AS versus HFrEF on patient outcomes remains unclear.
Purpose of the Study:
- To investigate the effect of moderate AS on mortality and heart failure hospitalization in patients with HFrEF.
- To assess the impact of aortic valve replacement (AVR) on survival in this patient cohort.
Main Methods:
- Matched cohort study comparing 262 patients with HFrEF and moderate AS to 262 patients with HFrEF and no AS.
- Patients were matched for key clinical characteristics including LVEF, NYHA class, and comorbidities.
- Primary endpoints included all-cause mortality and a composite of death and HF hospitalization.
Main Results:
- Moderate AS was associated with a nearly threefold increased risk of mortality (HR: 2.98) and a 2.3-fold increased risk for the composite endpoint.
- Aortic valve replacement (AVR) during follow-up was linked to improved survival (HR: 0.59).
- Transcatheter AVR showed a significant survival benefit (HR: 0.43), while surgical AVR did not reach statistical significance.
Conclusions:
- Moderate AS significantly elevates mortality risk in patients with HFrEF.
- Aortic valve replacement, especially transcatheter AVR, improves survival in HFrEF patients with moderate AS.
- Findings support a randomized trial for early transcatheter AVR in this population.
More Related Videos
Related Concept Videos
01:30Heart Failure V: Medical Management
61
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
61
01:25Aortic Regurgitation III: Medical Management
99
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
99
01:30Heart Failure IV: Classification and Diagnostic Evaluation
100
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
100
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
636
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
636
01:27Mitral Stenosis IV: Nursing Management
105
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
105
01:26Mitral Stenosis III: Medical Management
68
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
68